These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28334070)

  • 21. On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
    Duan R; Zhang X; Du J; Huang J; Tao C; Chen Y
    Health Informatics J; 2020 Jun; 26(2):753-764. PubMed ID: 30887861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Text and data mining for biomedical discovery.
    Gonzalez G; Cohen KB; Greene CS; Hahn U; Kann MG; Leaman R; Shah N; Ye J
    Pac Symp Biocomput; 2013; 2013():368-72. PubMed ID: 23424141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research.
    Zhang P; Wu HY; Chiang CW; Wang L; Binkheder S; Wang X; Zeng D; Quinney SK; Li L
    CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):90-102. PubMed ID: 29193890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.
    Trifirò G; Sultana J; Bate A
    Drug Saf; 2018 Feb; 41(2):143-149. PubMed ID: 28840504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mining in Twitter for adverse events from malaria drugs: the case of doxycycline.
    Duval FV; Silva FABD
    Cad Saude Publica; 2019 May; 35(5):e00033417. PubMed ID: 31141025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracting drug-enzyme relation from literature as evidence for drug drug interaction.
    Zhang Y; Wu HY; Du J; Xu J; Wang J; Tao C; Li L; Xu H
    J Biomed Semantics; 2016; 7():11. PubMed ID: 26955465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Next Generation of Drug Safety Science: Coupling Detection, Corroboration, and Validation to Discover Novel Drug Effects and Drug-Drug Interactions.
    Tatonetti NP
    Clin Pharmacol Ther; 2018 Feb; 103(2):177-179. PubMed ID: 29313964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portable automatic text classification for adverse drug reaction detection via multi-corpus training.
    Sarker A; Gonzalez G
    J Biomed Inform; 2015 Feb; 53():196-207. PubMed ID: 25451103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
    Coloma PM; Trifirò G; Patadia V; Sturkenboom M
    Drug Saf; 2013 Mar; 36(3):183-97. PubMed ID: 23377696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural Language Processing and Its Implications for the Future of Medication Safety: A Narrative Review of Recent Advances and Challenges.
    Wong A; Plasek JM; Montecalvo SP; Zhou L
    Pharmacotherapy; 2018 Aug; 38(8):822-841. PubMed ID: 29884988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database.
    Chasioti D; Yao X; Zhang P; Lerner S; Quinney SK; Ning X; Li L; Shen L
    IEEE J Biomed Health Inform; 2019 Sep; 23(5):2156-2163. PubMed ID: 30296244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions.
    Wu P; Nelson SD; Zhao J; Stone CA; Feng Q; Chen Q; Larson EA; Li B; Cox NJ; Stein CM; Phillips EJ; Roden DM; Denny JC; Wei WQ
    J Am Med Inform Assoc; 2021 Jul; 28(7):1421-1430. PubMed ID: 33712848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval.
    Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP
    Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using text-mining techniques in electronic patient records to identify ADRs from medicine use.
    Warrer P; Hansen EH; Juhl-Jensen L; Aagaard L
    Br J Clin Pharmacol; 2012 May; 73(5):674-84. PubMed ID: 22122057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A temporal interestingness measure for drug interaction signal detection in post-marketing surveillance.
    Ji Y; Ying H; Tran J; Dews P; Mansour A; Massanari RM
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2722-5. PubMed ID: 25570553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of listening social media for pharmacovigilance purposes: a systematic review.
    Convertino I; Ferraro S; Blandizzi C; Tuccori M
    Expert Opin Drug Saf; 2018 Nov; 17(11):1081-1093. PubMed ID: 30285501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features.
    Nikfarjam A; Sarker A; O'Connor K; Ginn R; Gonzalez G
    J Am Med Inform Assoc; 2015 May; 22(3):671-81. PubMed ID: 25755127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social media and pharmacovigilance: A review of the opportunities and challenges.
    Sloane R; Osanlou O; Lewis D; Bollegala D; Maskell S; Pirmohamed M
    Br J Clin Pharmacol; 2015 Oct; 80(4):910-20. PubMed ID: 26147850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel data-mining methodologies for adverse drug event discovery and analysis.
    Harpaz R; DuMouchel W; Shah NH; Madigan D; Ryan P; Friedman C
    Clin Pharmacol Ther; 2012 Jun; 91(6):1010-21. PubMed ID: 22549283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.